ArticleTranslational cancer research2025
Erratum: PA-MSHA exerts potent activity against cetuximab-resistant colorectal cancer through the miR-7-5p/Akt3/Wnt-β-catenin pathway.
Editorial OfficePubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.